Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: direct medical costs hypoglycemia hospitalizations us
… Evidence Assessment for a Digital Medical Technology OPPORTUNITY Our client’s digital … evidence. APPROACH We assembled a team of HEOR and medical technology experts to review the client’s data. Our … of Medtech Innovation Briefings and NICE guidance on medical devices, diagnostics, and digital technologies. Our …
… (DRE) utilize more health care resources and face higher costs than patients who can control their condition with … of seizures for some patients. However, the up-front costs for placing the device along with additional costs for … in addition to AEDs versus those taking AEDs alone in the US. Molly Purser, PhD, Associate Director of Health Economics …
… cost and utility estimates, and difficulty quantifying the costs and disutility of long-term steroids use. We recommend …
… challenge. Eight independent modeling groups from the US and Europe, including researchers from RTI Health …
… translated to higher quality-adjusted life-years and lower costs for natalizumab compared with fingolimod. In addition …
Tailoring Cost-Effectiveness Modeling Methodologies for Multiple Sclerosis Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in patients with inadequate response to disease-modifying therapies in relapsing-remitting multiple …
… Submission Requirements of Nordic HTA Organizations for Medical Technologies Maria Kinderås, MSc Senior Associate, … for a while, HTA organizations have in recent years taken medical technologies under their wings as well. Nordic … of Nordic health technology assessment organisations for medical technologies: results of an online survey . Poster …
… American Medical Writers Association - Carolinas Chapter Spring … Website Research coauthored by RTI Health Solutions medical writers and graphic designers will be presented at the 2022 American Medical Writers Association Carolinas Chapter Spring …
… (evLYG) An alternative method for estimating societal costs when data are lacking Potential other benefits and … being assessed. Although this new rating may not have a direct impact on how payers view the clinical effectiveness … and 2021. The evolution of ICER's review process for new medical interventions and a critical review of economic …
Cost-Effective Second-Line ADHD Drug with Better Efficacy Reported Share on: August 25, 2016 About one-third of patients with ADHD have an inadequate response to initial stimulant treatment and consequently might be considered for treatment with one of …